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Abstract. We studied the effects of interleukin (IL)-1β on DNA synthesis 
and cell proliferation in primary cultures of adult rat hepatocytes in order 
to elucidate the mechanisms of its action. Hepatocyte parenchymal cells 
maintained in a serum-free, defined medium synthesized DNA and 
proliferated in the presence of IL-1β (3-30 ng/ml), but not IL-1α (0.1-30 
ng/ml) in a time- and dose-dependent manner. Specific inhibitors of 
growth-related signal transducers, such as AG1478, LY294002, PD98059, 
and rapamycin, completely abolished IL-1β-stimulated hepatocyte DNA 
synthesis and proliferation. Western blot analysis showed that IL-1β 
significantly stimulated mitogen-activated protein (MAP) kinase activation 
within 10 min. Addition of a monoclonal antibody against transforming 
growth factor (TGF)-α, but not a monoclonal antibody against insulin-like 
growth factor-I, to the culture dose-dependently inhibited IL-1β-induced 
hepatocyte mitogenesis. Culture medium TGF-α levels increased 
significantly within 3 min in response to IL-1β from baseline levels. Peak 
TGF-α levels (33 pg/ml) were reached at 10 min after IL-1β stimulation. 
These results indicate that the proliferative mechanism of action of IL-1β is 
mediated through an increase in autocrine secretion of TGF-α from 
primary cultured hepatocytes. Secreted TGF-α, in turn, acts as a complete 
mitogen to induce hepatocyte mitogenesis through the receptor tyrosine 
kinase/phosphatidylinositol 3-kinase/MAP kinase/mammalian target of 
rapamycin pathway. 
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1. Introduction 
Adult rat hepatocytes rarely divide under normal physiological conditions. 
However, they remain capable of proliferation, and after hepatic resection, 
there is a prompt regenerative response to recruit mature hepatocytes into 
the cell cycle in vivo (Diehl and Rai, 1996; Galun and Axelrod, 2002). A 
variety of growth factors have been proposed to be involved in hepatocyte 
proliferation in vivo (Michalopoulos and DeFrances, 1997; Fausto et al., 
2006). On the other hand, adult rat hepatocytes in primary culture can 
proliferate when cultured at low cell density in the presence of appropriate 
growth factors or cytokines such as hepatocyte growth factor (HGF), 
epidermal growth factor (EGF), insulin, transforming growth factor-α 
(TGF-α) and tumor necrosis factor (TNF)-α (Kimura and Ogihara, 1997a, 
1997b, 1997c, 1999; Okamoto et al., 2009). Therefore, primary cultures of 
adult rat hepatocytes are an excellent model system in which to study the 
mechanisms that control parenchymal cell proliferation.  
The interleukin (IL)-1 family includes the structurally related proteins 
IL-1α, IL-1β and IL-1 receptor antagonist (IL-1ra), which bind to cell 
surface receptors. IL-1α and IL-1β are cytokines that have a wide array of 
effects on inflammatory and immune activity (Arend, 1991; Dripps et al., 
1991; Li and Qin, 2005). There are conflicting data regarding the direct 
effects of IL-1s on cell proliferation. It has been reported that IL-1β can act 
as a growth factor for various cells, such as fibroblasts, airway smooth 
 3 
muscle cells (Zhai et al., 2004), human astrocytoma cells (Lachman et al., 
1987) and gastric epithelial cells (Beales, 2002). In contrast, cell growth 
inhibition by IL-1β has been observed in cultured melanoma and breast 
carcinoma cells (Dinarello, 1996). These results suggest that IL-1β is a 
bifunctional growth regulator, depending on cell type and experimental 
conditions.  
In the liver, IL-1α  and IL-1β are predominantly produced by Kupffer cells 
in response to infectious and inflammatory stimuli and play a significant 
role in the regulation of hepatocyte mitogenesis (Diehl and Rai, 1996). 
There have been few studies on the effects of IL-1s on hepatocyte DNA 
synthesis and cell proliferation in primary cultures of adult rat hepatocytes 
(Boulton et al., 1997; Nakamura et al., 1988; Wang et al., 1998). Nakamura 
et al. first reported that IL-1β strongly inhibited hepatocyte DNA synthesis 
induced by insulin plus EGF in primary cultures of adult rat hepatocytes. 
Although IL-1β inhibits EGF- and insulin-induced hepatocyte DNA 
synthesis, the mechanism of the inhibitory effects is yet to be established. 
On the other hand, the direct effects of IL-1s  on hepatocyte mitogenesis 
have not been extensively studied. The main purpose of the present study 
is to investigate how the proliferative mechanisms of IL-1β are mediated.  
Our results demonstrate that IL-1β, but not IL-1α, is a potent stimulator 
of DNA synthesis and cell proliferation in primary cultures of adult rat 
hepatocytes. The proliferative mechanisms of IL-1β are mediated by 
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autocrine secretion of the primary mitogen TGF-α from primary cultured 
hepatocytes, which, in turn, induces hepatocyte mitogenesis via the 
receptor tyrosine kinase/MAP kinase (extracellular signal-regulated 
kinase: ERK) signaling pathway.  
 
2. Materials and Methods 
 
2.1. Animals 
Male Wistar rats weighing 200 - 220 g were obtained from Tokyo 
Experimental Animal Co. (Tokyo, Japan). Adaptation to a light-, humidity- 
and temperature-controlled room occurred over a minimum 3-day period 
prior to the start of experiments. Rats were fed a standard diet and given 
tap water ad libitum. Animals used in this study were handled in 
accordance with the Guiding Principles for the Care and Use of Laboratory 
Animals approved by the Japanese Pharmacological Society. 
 
2.2. Hepatocyte isolation, culture and treatment 
Rats were anesthetized by intraperitoneal injection of sodium 
pentobarbital (45 mg/kg). Hepatocytes were isolated from normal livers by 
the two-step in situ collagenase perfusion technique devised by Seglen to 
facilitate disaggregation of the adult rat liver (Seglen, 1975). Viability as 
tested by Trypan blue exclusion was more than 97%. Unless otherwise 
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indicated, freshly isolated hepatocytes were plated onto collagen-coated 
plastic culture dishes (35 mm diameter; Iwaki Glass Co., Tokyo, Japan) at a 
density of 3.3 × 104 cells/cm2, and allowed to attach for 3 h on 
collagen-coated dishes in Williams’ medium E containing 5% newborn calf 
serum, 0.1 nM dexamethasone, 100 U/ml penicillin, 100 µg/ml streptomycin 
and 0.10 µg/ml aprotinin under 5% CO2 in air at 37ºC. Medium was then 
replaced by aspiration, and cells were further cultured in serum- and 
dexamethasone-free Williams’ medium E supplemented with IL-1α or IL-1β. 
When appropriate, following agents were added; IL-1α or IL-1β with or 
without U-73122, U-73343, GF109203X, H-89, 2, 4-dideoxyadenosine, 
verapamil, somatostatin and inhibitors of growth-related signal 
transducers (i.e., AG1478, LY294002, PD98059 and rapamycin). 
AG1478, LY294002, PD98059, U-73122, U-73343, GF109203X, and 
rapamycin were dissolved in 5% DMSO. All other agents were dissolved in 
phosphate-buffered saline (PBS; pH 7.4). 
Hepatocyte DNA synthesis was assessed by measuring [3H]-thymidine 
incorporation into acid-precipitable materials (Morley and Kingdon, 1972). 
After an initial attachment period of 3 h, hepatocytes were washed twice 
with serum-free Williams’ medium E, followed by culture in medium 
containing IL-1α or IL-1β for a further 4 h. Cells were pulse-stimulated for 
2 h with [3H]-thymidine (1.0 µCi/well) at 2 h following the addition of IL-1α 
or IL-1β. Incorporation of [3H]thymidine into DNA was determined as 
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described previously (Kimura and Ogihara, 1997a). Hepatocyte protein 
content was determined using a modified Lowry procedure (Lee and 
Paxman, 1972) with bovine serum albumin as a standard. Data are 
expressed as dpm/(h･mg cellular protein). 
The number of nuclei rather than the number of cells was counted, as 
described previously (Nakamura et al., 1983), but with minor modifications 
(Kimura and Ogihara, 1997a).  
 
2.3. Analysis of cell cycle by flow- and laser scanning-cytometry 
 Cell cycle progression by IL-1β was determined by using MuseTM cell cycle 
kit and MuseTM cell analyzer, in accordance with the manufacturer’s 
instructions (Millipore, Darmstadt, Germany). The assay system allows for 
the quantitative measurement of percentage of cells in the G0/G1, S, and 
G2/M phases of the cell cycle. The basic methodology of this assay system 
has been described elsewhere (Darzynkiewicz et al., 2010). Briefly, 
hepatocytes were cultured as described in Section 2.1. At each time point, 
hepatocytes were washed twice with ice-cold PBS, and were then 
solubilized with 0.1 M citrate-0.1% Triton X-100 solution and nuclei were 
isolated as described elsewhere (Kimura and Ogihara, 1997a). They were 
subjected to flow cytometry. Isolated nuclei rather than whole cells were 
analyzed because primary cultured hepatocytes are firmly attached to 
collagen-coated plastic dishes. The accuracy of DNA content measurement 
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for DNA ploidy or cell cycle phase estimation is much greater when isolated 
nuclei are analyzed rather than whole cells (Darzynkiewicz et al., 2010). 
However, this method may not detect mitotic cell nuclei, as the lysis of 
plasma membranes of mitotic cells lacking a nuclear envelope leads to 
dispersion of individual chromosomes.  
 
2.4. Determination of receptor tyrosine kinase and extracellular 
signal-regulated kinase (ERK 1/2) activation 
 A 175-kDa protein was identified as the EGF/TGF-α receptor by 
immunoblotting with anti-phosphoreceptor tyrosine kinase antibody in 
accordance to the manufacturer’s instructions, as described previously 
(Okamoto et al., 2009). Briefly, hepatocytes were freshly isolated and 
cultured as described in Section 2.2. Cultured hepatocytes were washed 
once with ice-cold phosphate-buffered saline (pH 7.4), and 1.2 ml of lysis 
buffer was added. Cell lysates were obtained by scraping cells in lysis 
buffer followed by sonication for 3 min. Cell lysates were centrifuged (3,000 
× g for 3 min at 4ºC) to remove cell debris, and were then denatured in 
boiling water for 5 min. For immunoblotting analysis, samples of 
supernatant (30 µg/lane) were resolved by SDS-polyacrylamide gel 
electrophoresis using a 7.5% polyacrylamide resolving gel (Laemmli, 1970), 
transferred to PVDF membrane and immunoblotted with the 
anti-phosphotyrosine antibody PY 20 (Towbin et al., 1979). Blots were 
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developed by enhanced chemiluminescence following incubation with 
HRP-conjugated secondary antibodies (Kimura et al., 2001). Proteins were 
quantified by densitometry after the membrane was developed with 
enhanced chemiluminescence reagent and exposure to Hyperfilm (Kodak, 
Tokyo). Densitometric analysis was performed using the NIH image 
program (ver. 1.6 for Macintosh). The tyrosine kinase activity of the 
phosphorylated p175-kDa protein (P-p175 kDa) was normalized against 
that of total p175-kDa protein. Supernatant protein concentration was 
determined using the modified Lowry method (Lee and Paxman, 1972).  
Cell lysis and Western blotting procedure were carried out as described 
above, except that 20 µg of supernatant was applied to each lane of a 10% 
polyacrylamide resolving gel. Phosphorylated ERK isoforms (P-ERK1, 
P-p44 MAPK; and P-ERK2, P-p42 MAPK) were identified by Western blot 
analysis using anti-phospho-ERK1/2 monoclonal antibody, as described 
previously (Towbin et al., 1979). Phosphorylated ERK (P-ERK) activity was 
normalized against total ERK activity. Data were calculated in terms of 
arbitrary units and are expressed as means ± S.E.M. The autodiagram is a 
representation of three experiments using different cell preparations.  
Cytosolic protein in hepatocytes was quantified using a modification of 
the Lowry procedure with bovine serum albumin as a standard (Lee and 
Paxman, 1972). 
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2.5. Neutralization of endogenous growth factors and assay of TGF-α levels 
in culture medium 
In experiments employing neutralizing antibodies, serum-free primary 
cultured hepatocytes were treated with 10 ng/ml IL-1β in the presence or 
absence of varying concentrations of human IgG, monoclonal antibodies 
against IGF-I or TGF-α (12.5, 25, 37.5, 50, 62.5 or 80 ng/ml). 
As some ingredients of Williams’ medium E interfere with the 
enzyme-linked immunosorbent assay (ELISA) system, TGF-α secretion into 
a phosphate-buffered conditioned medium after addition of 10 ng/ml IL-1β 
with or without test substances was measured as described previously 
(Kimura et al., 2001). Briefly, after an attachment period of 3 h, cultured 
hepatocytes were washed three times with phosphate-buffered saline (PBS; 
pH 7.4) and culture medium was replaced with PBS containing 1.0 mM 
CaCl2, 5.5 mM glucose and 0.10 µg/ml aprotinin (pH 7.4). Hepatocytes were 
preincubated in conditioned medium for 5 min in humidified 5% CO2-95% 
air at 37ºC, and were then stimulated with 10 ng/ml IL-1β in the absence or 
presence of test substances. At each time point, conditioned medium (50 µl) 
was collected and medium samples were tested with an ELISA kit for 
TGF-α according to the manufacturer’s protocols (Calbiochem, San Diego, 
CA). Absorbance was determined at 490-nm using a micro-plate reader 
(Tecan Japan, Kanagawa, Japan). A standard curve was obtained in a 
linear range of 15.6 - 800 pmol/ml, with a minimum detectable limit of 
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about 7.8 pmol/ml. 
 
2.6. Materials 
The following reagents were obtained from Sigma Chemical Co. (St. Louis, 
MO); human recombinant IL-1α, IL-1β, human IgG, aphidicolin, 
dexamethasone, somatostatin, verapamil hydrochloride and aprotinin. 
Monoclonal antibodies against IGF-I were obtained from Oncogene 
Research Products (San Diego, CA). IL-1ra was obtained from R & D 
systems (Minneapolis, MN). Monoclonal antibody against TGF-α and 
BAPTA/AM [1,2-Bis(2-aminophenoxy)ethane-N, N, N’, N’-tetraacetic acid 
tetrakis(acetoxymethyl ester)] was obtained from Santa Cruz 
Biotechnology (Dallas, TX). U-73122 (1-[6-[17β-3-methoxyestra-1, 3, 
5(10)-trien-17-yl]-amino] hexyl]-1H-pyrrol-2, 5-dione), U-73343 
(1-[6-[17β-3-methoxyestra-1, 3, 5(10)-trien-17-yl]-amino] hexyl]-2, 
5-pyrrolidine-dione), GF109203X 
(2-[1-(3-Dimethylaminopropyl)-1H-indol-3-yl]-3-(1H-indol-3-yl)maleimide), 
2,4-dideoxyadenosine, H-89 (N-[2-(p-bromocinnamylamino) 
ethyl]-5-isoquinolinesulfonamide dihydrochloride), AG1478 
(2-[4-morpholinyl]-8-phenyl-1(4H)-benzopyran-4-one), LY294002 
(N-[3-chlorophenyl]-6,7-dimethoxy-4-quinazolinamine) and rapamycin were 
obtained from Enzo Life Sciences, Inc. (Farmingdale, NY). PD98059 
(2’-amino-3’-methoxyflavone) was obtained from Calbiochem-Behring (La 
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Jolla, CA). Williams’ medium E and newborn calf serum were purchased 
from Flow Laboratories (Irvine, Scotland). Collagenase (type II) was 
obtained from Worthington Biochemical Co. (Freehold, NJ). [Methyl-3H] 
thymidine (20 Ci/mmol) was purchased from DuPont-New England Nuclear 
(Boston, MA). ELISA kit for TGF-α was obtained from Calbiochem (San 
Diego, CA). MuseTM cell cycle kit was obtained from Millipore (Darmstadt, 
Germany). All other reagents were of analytical grade. 
 
2.7. Statistical analysis 
Data are expressed as means ± S.E.M. Group comparisons were made by 
analysis of variance (ANOVA) for unpaired data, followed by post-hoc 
analysis using Dunnett’s multiple comparison test. Differences of P < 0.05 
were considered to be statistically significant. 
 
 
 
 
 
 
 
 
 12 
3. Results 
 
3.1. Time course of induced stimulation of hepatocyte DNA synthesis and 
proliferation by IL-1β 
We examined the effects of IL-1α and IL-1β on DNA synthesis and 
proliferation in primary cultures of adult rat hepatocytes in the absence of 
exogenously added primary mitogens such as EGF and insulin. IL-1α (30 
ng/ml) and IL-1β (10 ng/ml) were added 3 h after plating when the change 
to serum-free culture medium was made (Fig. 1). When maintained for a 
short time in culture medium, hepatic parenchymal cells underwent 
time-dependent DNA synthesis and proliferation (i.e., an increase in the 
number of nuclei) in the presence of IL-1β (10 ng/ml), but not IL-1α (30 
ng/ml). The onset of DNA synthesis was first observed at about 2.0 h and 
peaked at about 3.5 h after addition of IL-1β (Fig. 1A), while significant 
mitotic activity was observed at 3 h and peaked at about 4.0 h (Fig. 1B). 
Maximal stimulation of hepatocyte DNA synthesis and proliferation by 10 
ng/ml IL-1β was about 8.0-fold and 1.2-fold, respectively. DNA synthesis 
and proliferative effects of 10 ng/ml IL-1β on primary cultured hepatocytes 
were almost completely inhibited by 20 ng/ml IL-1ra.   
 
3.2 Effects of IL-1α and IL-1β on cell cycle progression in primary cultures 
of adult rat hepatocytes 
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  We then examined effects of IL-1α (30 ng/ml) and IL-1β (10 ng/ml) on cell 
cycle progression in primary cultures of adult rat hepatocytes. Fig.2A 
shows that percent of total hepatocyte nuclei for G0/G1 phase of the cell 
cycle decreased significantly during the 3-h attachment period. The percent 
of total hepatocyte nuclei for the G0/G1 phase of the cell cycle decreased 
significantly during further 4-h culture in medium-treated control cells. 
Percentages further decreased significantly when IL-1β (10 ng/ml) or EGF 
(20 ng/ml) was added to the culture when compared with the respective 
control (medium alone) at 2 h and 3 h after addition of primary mitogen 
growth factor.  
Fig. 2B shows that percent of total hepatocyte nuclei for S phase of the cell 
cycle did not change significantly during 3-h attachment period. The 
percent of total hepatocyte nuclei for S phase of the cell cycle did not 
increase significantly during further 4-h culture in medium-treated control 
or IL-α (30 ng/ml)-treated cells. In contrast, percentages were found to be 
significantly higher when IL-1β (10 ng/ml) or EGF (20 ng/ml) was added to 
culture when compared with the respective control (medium alone) at 1, 2, 
3 and 4 h after addition of primary mitogens.  
 
3.3. Dose-response effects of IL-1β  on hepatocyte DNA synthesis and 
proliferation, and its blockade by IL-1ra 
We then examined the dose-response relationship between IL-1β and 
 14 
hepatocyte mitogenesis. IL-1β-induced [3H]thymidine incorporation (i.e., 
DNA synthetic activity) was dose-dependent and plateaued at 10 ng/ml, 
with a half-maximal effective concentration (ED50) value of 2.2 ng/ml (Fig. 
3A). The proliferative effects of the IL-1β on cultured hepatocytes were very 
similar to those effects on DNA synthesis. In contrast, the effects of IL-1α 
on hepatocyte DNA synthesis and proliferation were negligible, being in the 
concentration range of 0.1 to 30 ng/ml (Fig. 3A). 
 As shown in Fig. 3B, DNA synthesis and proliferative effects of 10 ng/ml 
IL-1β on primary cultured hepatocytes were almost completely inhibited by 
30 ng/ml IL-1ra with a half-maximal inhibitory concentration (IC50) value 
of 7.2 and 7.1 ng/ml. 
 
3.4. Effects of specific inhibitors of growth-related signal transducers on 
hepatocyte DNA synthesis and proliferation induced by IL-1β 
  We next investigated whether the mitogenic responses of hepatocytes to 
IL-1β were mediated by signal transducers, such as receptor tyrosine 
kinase, phosphatidylinositol 3-kinase (PI3K), mitogen-activated protein 
(MAP) kinase kinase and mammalian target of rapamycin (mTOR), an 
upstream element of ribosomal protein p70 S6 kinase using the 
corresponding specific inhibitors of the signal transducers, AG1487 (10-6 M), 
a specific inhibitor of receptor tyrosine kinase, LY294002 (3×10-7 M), a 
specific inhibitor of PI3K, PD98059 (10-6 M), a specific inhibitor of ERK, 
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and rapamycin (10 ng/ml), a specific inhibitor of mTOR. When combined, 
AG1487 (10-6 M), LY294002 (3×10-7 M), PD98059 (10-6 M) and rapamycin 
(10 ng/ml) almost completely inhibited the IL-1β-induced hepatocyte DNA 
synthesis and proliferation during the early (Fig. 4A and B) and late phases 
of culture (data not shown), thus suggesting involvement of receptor 
tyrosine kinase, PI3K, ERK and mTOR. In addition, possible involvement 
of phospholipase C (PLC) in the IL-1β-induced hepatocyte DNA synthesis 
and proliferation was examined using U-73122. U-73122 (10-6 M) produced 
attenuation of IL-1β-induced hepatocyte DNA synthesis and proliferation, 
but U-73343, an inactive structural analogue, did not. GF109203X (10-6 M), 
a specific protein kinase C inhibitor did not inhibit IL-1β-induced 
hepatocyte DNA synthesis and proliferation. Furthermore, IL-1ra (20 
ng/ml) inhibited IL-1β-induced hepatocyte DNA synthesis and proliferation. 
These specific inhibitors alone had no effect on hepatocyte DNA synthesis 
and proliferation.  
 
3.5. Time-course and patterns of IL-1β stimulation of ERK isoform 
phosphorylation 
 We then examined the time-course and patterns of IL-1β stimulation of 
ERK isoform phosphorylation in primary cultured hepatocytes, as detected 
by Western blot analysis. The phosphorylated ERK2 band (P-ERK2) was 
induced after only 3 min, and peaked (about 3-fold increase) between 5 and 
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10 min after addition of 10 ng/ml IL-1β (Figs. 5A, B). ERK1 
phosphorylation was not significantly affected by either medium alone 
(control) or by 10 ng/ml IL-1β treatment (Figs. 5A, C).  
   
3.6. Effects of specific inhibitors of growth-related signal transducers on 
ERK phosphorylation induced by IL-1β  
In order to obtain further support for ERK mediation of hepatocyte 
mitogenesis induced by IL-1β, we examined the effects of specific 
inhibitors of growth-related signal transducers on ERK2 phosphorylation 
induced by 10 ng/ml IL-1β for 10 min. Fig. 6A shows that IL-1β caused an 
increase in the phosphorylation of ERK2, but not ERK1. The 
phosphorylation of ERK 2 was completely inhibited by the IL-1β receptor 
antagonist IL-1ra at 20 ng/ml. When IL-1β was added in combination with 
PD98059 (10-6 M), the agent completely abolished IL-1β-induced ERK2 
phosphorylation (Fig. 6A). Moreover, ERK2 phosphorylation induced by 
IL-1β was abolished by receptor tyrosine kinase inhibitor AG1478 (10-6 M) 
or PI3K inhibitor LY294002 (3x10-7 M), but not by rapamycin (10 ng/ml) 
(Fig. 6A). These results suggest that the mitogenic effects of IL-1β were 
mediated through activation of the receptor tyrosine kinase/PI3K/ERK 2 
pathway. As U-73122 (10-6 M), verapamil (10-6 M) and somatostatin (10-7 
M) inhibited IL-1β-induced ERK2 phosphorylation, IL-1β-mediated 
responses were modulated by PLC and extracellular Ca2+, which is closely 
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associated with cell proliferation in primary cultures of adult rat 
hepatocytes (Fig. 6B). On the other hand, GF109203X (10-6 M), 
dideoxyadenosine and H-89 did not affect IL-1β-induced ERK2 
phosphorylation, suggesting that protein kinase C, adenylate cyclase and 
protein kinase A are not likely to be involved in IL-1β-induced ERK2 
phosphorylation (Fig. 6B). 
 
3.7. Effects of monoclonal antibodies against TGF-α or IGF-I on hepatocyte 
DNA synthesis and proliferation induced by IL-1β 
 Figs. 7A and 7B show that the addition of a neutralizing monoclonal 
antibody against TGF-α (1- 80 ng/ml) dose-dependently inhibited the 
growth-promoting effects of IL-1β (10 ng/ml) on hepatocyte DNA synthesis 
and proliferation, suggesting involvement of endogenous TGF-α secretion. 
IC50 values for these DNA synthetic and proliferative effects after 4 h of 
culture were 34 ng/ml and 38 ng/ml, respectively. In contrast, DNA 
synthetic and proliferative effects of IL-1β (10 ng/ml) were not affected 
significantly by treatment of hepatocytes with various concentrations of 
monoclonal antibody against IGF-I (1 - 80 ng/ml). Addition of human IgG 
protein (1- 80 ng/ml) to cultured hepatocytes had no significant effect on 
hepatocyte DNA synthesis or proliferation induced by 10 ng/ml IL-β (data 
not shown). These monoclonal antibodies alone or human IgG protein did 
not significantly influence hepatocyte DNA synthesis or proliferation 
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during 4 h of culture (data not shown).  
 
3.8. Effects of specific inhibitors of growth-related signal transducers on 
phosphorylation of receptor tyrosine kinase induced by IL-1β 
 In order to confirm the notion that IL-1β induces hepatocyte DNA 
synthesis and proliferation through TGF-α receptor tyrosine kinase/ERK 
signaling pathway, we investigated whether IL-1β can actually stimulate 
phosphorylation of TGF-α receptor tyrosine kinase (p175 kDa). Fig. 8 
shows that 10 ng/ml IL-1β caused an increase in the phosphorylation of 
TGF-α receptor tyrosine kinase (p175 kDa), peaking at about 2.4-fold 
(compared with controls) at 3 min after addition. IL-1ra (20 ng/ml) 
completely inhibited the IL-1β-induced phosphorylation of TGF-α receptor 
tyrosine kinase. AG1478 (10-6 M) significantly inhibited IL-1β-induced 
phosphorylation of TGF-α receptor tyrosine kinase. The PLC inhibitor 
U-73122 completely inhibited the IL-1β-induced phosphorylation of TGF-α 
receptor tyrosine kinase. In contrast, LY294002, PD98059 and rapamycin 
did not affect the IL-1β-induced phosphorylation of TGF-α receptor tyrosine 
kinase. These inhibitors alone did not affect the IL-1β-induced 
phosphorylation of TGF-α receptor tyrosine kinase. 
 
3.9. IL-1β-induced increases in TGF- α in culture: time course study and 
dose-response relationship 
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In order to verify the model proposed above, it was important to 
demonstrate that treatment of primary cultured hepatocytes with IL-1β 
does in fact lead to increased secretion of TGF-α. We thus determined the 
culture medium TGF-α levels. A time course study showed that a 
detectable increase was seen within 3 min after 10 ng/ml IL-1β treatment, 
as compared with controls (Fig. 9A). Maximal levels (33 pg/ml) were 
reached at 10 min after IL-1β stimulation. When combined, IL-1ra (20 
ng/ml) completely inhibited the IL-1β-induced secretion of TGF-α into 
culture medium. TGF-α levels remained significantly elevated for the 
duration of the experiment. The addition of IL-1α (30 ng/ml) alone had no 
significant effect (0 - 30 min) on TGF-α levels in culture medium. 
As shown in Fig. 9B, IL-1β induced dose-dependent increases in the 
culture medium TGF-α levels during 10-min culture, with ED50 values of 
2.5 ng/ml. The addition of IL-1α (0.1 - 30 ng/ml) to cultured hepatocytes 
had no significant effect on TGF-α levels in culture medium. 
 
3.10. Regulation of IL-1β-induced increase in culture medium TGF-α levels: 
effects of inhibitors of the IL-1β receptor/phospholipase C pathway 
In order to investigate the signal transducing mechanisms that mediate 
the IL-1β-induced increases in culture medium TGF-α levels by primary 
cultured hepatocytes, we examined the effects of PLC inhibitor U-73122, 
PKC inhibitor GF109203X, membrane-permeable chelator of Ca2+ 
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BAPTA/AM somatostatin, and L-type Ca2+ channel blocker verapamil. As 
shown in Fig. 10, the increase in TGF-α levels by 10 ng/ml IL-1β treatment 
was completely inhibited by IL-1ra (20 ng/ml). Addition of U-73122 (10-6 M) 
almost completely inhibited the 10 ng/ml IL-1β-induced increase in culture 
medium TGF-α levels, thus suggesting that PLC is closely involved in 
TGF-α secretion by cultured hepatocytes. Next, we evaluated the effects of 
somatostatin, which inhibits the release of certain gastrointestinal and 
pancreatic hormones (presumably by affecting decreasing cytosolic Ca2+ 
levels or attenuating cAMP levels) on the increase in culture medium 
TGF-α levels by 10 ng/ml IL-1β stimulation. Treatment of cultured 
hepatocytes for 30 min with somatostatin (10-7 M) caused marked 
inhibition of TGF-α release. In addition, the IL-1β-induced increase in 
TGF-α levels was also inhibited by verapamil (10-6 M) and BAPTA/AM (10-7 
M). Moreover, this increase in TGF-α levels was not affected by GF109203X 
(10-6 M) (Fig. 10). In addition, the growth-related signal transducer 
inhibitors AG1478, LY294002, PD98059 and rapamycin had no significant 
effects on the IL-1β-induced increase in TGF-α secretion into culture 
medium. These inhibitors alone did not affect basal TGF-α levels. 
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4. Discussion 
It has been reported that IL-1β strongly inhibits hepatocyte DNA 
synthesis induced by EGF and insulin in primary cultures of adult rat 
hepatocytes (Nakamura et al., 1988). They identified a unique high-affinity 
IL-1 receptor (i.e., type I receptor), which specifically binds the IL-1β, but 
not IL-1α, present on adult rat hepatocytes. Cloning of type I IL-1 receptor 
showed that it did not possess intrinsic tyrosine kinase activity, and the 
same is true for the low-affinity IL-1 receptor (i.e., type II receptor) (Kohira 
et al., 1993). However, why IL-1β inhibited hepatocyte DNA synthesis in 
the presence of EGF and insulin remains to be clarified (Nakamura et al., 
1988; Wang et al., 1998).  
On the other hand, we demonstrated that IL-1β, but not 
IL-1α, significantly induced time- and dose-dependent increases in DNA 
synthesis and proliferation in primary cultures of adult rat hepatocytes in 
the absence of exogenous primary growth factors or cytokines such as HGF, 
EGF, insulin and TGF-α (Figs. 1 and 3). As shown in Figs. 1 and 3, we 
found that the growth-promoting effects of IL-1β are completely inhibited 
by an antagonist of IL-1β receptor, IL-1ra (Dripps et al., 1991; Wang, et al., 
1998), confirming that IL-1β apparently acts as complete mitogen via the 
IL-1β receptor in primary cultures of adult rat hepatocytes. However, the 
results in Fig. 1 show that the doubling time of primary cultured 
hepatocytes is about 3 - 4 h after IL-1β treatment. This appears to be very 
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fast. Therefore, we performed cell cycle analysis during primary culture. 
Under our culture conditions (i.e., low cell density and low dexamethasone), 
hepatocytes were able to progress from G0 to G1 phase in the absence of 
primary mitogens during the 3-h attachment period. These hepatocytes 
were arrested in the G1 phase, and further progression to S phase was 
found to be dependent on IL-1β or EGF addition (Figs. 2A and 2B). It has 
also been reported that collagenase perfusion of the liver triggers the G0/G1 
transition of quiescent normal rat hepatocytes (Loyer et al., 1996). 
Progression in G1 is essential for making hepatocytes competent with 
growth factor (Collin de l’Heuter et al., 2012). 
We then investigated the post-receptor mechanisms responsible for the 
proliferative action of IL-1β, as well as the intracellular signal transduction 
mechanisms. Specific inhibitors of growth-related signal transducers, such 
as U-73122 (Thompson et al., 1991), AG1478 (Levitzki and Gazit, 1995), 
LY294002 (Vlahos et al., 1994), PD98059 (Alessi et al., 1995) and 
rapamycin (Chung al., 1992) almost completely attenuated 
IL-1β-stimulated hepatocyte DNA synthesis and proliferation (Fig. 4). 
Inhibitor study suggests that mitogenic signaling through the IL-1β 
receptor pathway requires activation of PLC, receptor tyrosine kinase, 
PI3K, ERK (Davis, 1993) and mTOR, respectively (Fig. 4). As described 
above, however, IL-1β receptor does not possess intrinsic tyrosine kinase 
activity (Kohira et al., 1993). Therefore, it remains to be elucidated how 
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these factors are associated with one another. On the other hand, it is 
unlikely that IL-1β receptor/(Gq)/PLC/protein kinase C, or adenylate 
cyclase/protein kinase A pathway contributes to IL-1β-induced hepatocyte 
mitogenesis, as the specific inhibitor of protein kinase C GF109203X 
(Toullec et al., 1991), the direct inhibitor of adenylate cyclase 
2,4-dideoxyadenosine (Holgate et al., 1980), nor the inhibitor of protein 
kinase A H-89 (Zusick et al., 1994) affected DNA synthesis and 
proliferation (Fig. 4). 
In order to further support receptor tyrosine kinase/MAP kinase 
mediation of the IL-1β action, we first examined the effects of IL-1β on 
ERK activation. As shown in Figs. 5 and 6, IL-1β  induced phosphorylation 
of ERK, and this was inhibited specifically by PD98059. These results are 
consistent with those reported in other cell types (Beales, 2002; Tominaga 
et al., 2000; Yang et al., 2000; Zhai et al., 2004). In addition, IL-1β-induced 
phosphorylation of ERK was completely inhibited by IL-1ra and AG1478 
(Fig. 6A). We then investigated the mechanisms by which IL-1β-stimulated 
hepatocyte mitogenesis and receptor tyrosine kinase/ERK-mediated 
pathways are associated with one another. As shown in Fig. 5, we found 
that IL-1β stimulates ERK2 phosphorylation, but not ERK1 
phosphorylation. Carcamo-Orive et al. demonstrated that continued 
expression of cyclin-D1 in the G0/G1 phase is dependent on ERK2 
expression by PDGF, and that the ablation of ERK1 influences neither the 
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proliferation capacity of human mesenchymal stem cells, nor the 
expression pattern of cyclin-D1. In agreement with a recent report, our 
results indicated that ERK2 play a key role in hepatocyte proliferation. The 
involvement of ERK2 in the IL-1β-induced hepatocyte proliferation was 
almost completely blocked by the MEK inhibitor PD98059 (Fig. 6A). 
In previous studies, we demonstrated that prostaglandin E1, IP receptor 
agonist and TNF-α induced hepatocyte DNA synthesis and proliferation 
through autocrine secretion of complete mitogen TGF-α, which, in turn, 
stimulated hepatocyte mitogenesis through TGF-α receptor tyrosine 
kinase/ERK pathway (Kimura et al., 2001, Kimura et al., 2009, Okamoto et 
al., 2009). Therefore, we hypothesized that the IL-1β 
receptor/(Gq)/PLC/Ca2+ pathway stimulates secretion of a complete mitogen 
by primary cultured hepatocytes in an autocrine manner, inducing 
hepatocyte DNA synthesis and cell proliferation through stimulation of the 
downstream receptor tyrosine kinase/ERK pathway. Either TGF-α or IGF-I 
is a potential candidate as the primary growth factor, since hepatocytes 
express mRNA for both TGF-α and IGF-I, and the cells can synthesize and 
store these primary growth factors (Michalopoulos and DeFrances, 1997).  
In order to investigate the possibility that TGF-α or IGF-I mediates 
IL-1β-induced hepatocyte DNA synthesis and proliferation in primary 
cultures, we examined the effects of neutralizing monoclonal antibodies 
against TGF-α and IGF-I on the hepatocyte mitogenesis induced by IL-1β. 
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As shown in Fig. 7, the results clearly indicated that IL-1β-induced 
hepatocyte DNA synthesis and proliferation were almost completely 
inhibited by a monoclonal antibody against TGF-α, but not by a monoclonal 
antibody against IGF-I. Therefore, the results suggest that cytokine TGF-α 
is stored within the parenchymal hepatocytes and is triggered to secrete to 
the culture medium through IL-1β stimulation. Moreover, with regard to 
the action of endogenous TGF-α, we showed that 10 ng/ml IL-1β 
stimulation caused a rapid increase in phosphorylation of TGF-α receptor 
tyrosine kinase (p175kDa). IL-1ra and AG1478 completely antagonized the 
IL-1β-induced phosphorylation of TGF-α receptor tyrosine kinase (Fig. 8).  
In order to verify the model proposed above, it is important to 
demonstrate that treatment of primary cultured hepatocytes with IL-1β 
does in fact lead to increased secretion of TGF-α into culture. We obtained 
data showing that IL-1β  produced significant time- and dose-dependent 
increases in TGF-α in the culture medium (Fig.9A and B). In addition, 
according to our previous study on the TGF-α signaling system in primary 
cultures of adult rat hepatocytes (Kimura and Ogihara, 1999), the 
growth-promoting signaling of TGF-α is mainly mediated through the 
receptor tyrosine kinase/PI3K/ERK/mTOR pathway. Thus, the TGF-α 
releasing action of IL-1β appears to be sufficient to explain the 
phenomenon of induced DNA synthesis and proliferation in primary 
cultures of adult rat hepatocytes. 
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The relationships between IL-1β-induced TGF-α secretion and hepatocyte 
mitogenesis were confirmed by investigating the regulatory mechanisms 
behind the rapid increase in culture medium TGF-α levels by IL-1β 
receptor stimulation. As shown in Fig. 4, IL-1β-induced hepatocyte 
mitogenesis was inhibited by the PLC inhibitor U-73122 (Thompson et al., 
1991), but not by its inactive analog, U-73343. Therefore, the functional 
IL-1β receptors found in hepatocytes in primary cultures are likely to 
stimulate PLC and increase Ca2+ mobilization  to secrete TGF-α as a 
primary mechanism of IL-1β-induced hepatocyte DNA synthesis and 
proliferation (Figs. 4 and 10). The importance of intracellular Ca2+ was 
further supported by the observation that the L-type Ca2+ channel blocker 
verapamil and BAPTA/AM (Szabo et al., 2008) inhibit hepatocyte DNA 
synthesis and proliferation induced by IL-1β (data not shown)  by inhibiting 
TGF-α secretion (Fig. 10). In addition, somatostatin strongly inhibited 
IL-1β-induced ERK2 phosphorylation by inhibiting TGF-α secretion (e.g., 
Figs. 6B and 10). Taken together, these observations indicate the need for 
increases in intracellular Ca2+ during IL-1β-induced hepatocyte DNA 
synthesis and proliferation, which is mediated through autocrine secretion 
of TGF-α. In support of our findings, it has been reported that PLC 
mediates IL-1β receptor-stimulated mucin secretion in middle ear 
epithelial cells (Kerschner et al., 2006). 
On the other hand, it is unlikely that IL-1β receptor/(Gq)/PLC/protein 
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kinase C, or the adenylate cyclase/protein kinase A pathway contributes to 
IL-1β-induced hepatocyte mitogenesis, as the inhibitor of protein kinase C 
GF109203X, the direct inhibitor of adenylate cyclase 2,4-dideoxyadenosine, 
and the inhibitor of protein kinase A H-89 had no effect on DNA synthesis 
and proliferation or ERK activation (Figs. 4 and 6B). In addition, the 
growth-related signal transducer inhibitors AG1478, LY294002, PD98059 
and rapamycin had no significant effects on IL-1β-induced increases in 
culture medium TGF-α levels (Fig. 10). These agents only blocked IL-1β 
receptor signaling by inhibiting corresponding growth-related signal 
transducer activities induced by TGF-α, thereby blocking hepatocyte DNA 
synthesis and proliferation (Figs. 4A and B). Consequently, the suppression 
of IL-1β receptor signaling by these specific growth-related signal 
transducer inhibitors may occur downstream of TGF-α secretion. Taken 
together, our findings confirm that the ability of IL-1β to promote 
hepatocyte mitogenesis is due to an indirect effect of secreted TGF-α in an 
autocrine manner. This is a unique intracellular signal transduction 
mechanism when compared with classical growth factors such as EGF, 
HGF and insulin. 
Based on the above biochemical and pharmacological analysis, we propose 
that IL-1β receptor is linked to a G-protein (possibly Gq) and stimulates 
the activity of PLC. This causes an increase in intracellular Ca2+ levels, 
which induces TGF-α secretion in an autocrine manner. The secreted 
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TGF-α can induce hepatocyte DNA synthesis and proliferation via the 
TGF-α receptor tyrosine kinase/PI3K/ERK/mTOR pathway. A diagram of 
the proposed mechanism for this IL-1β receptor-mediated signaling 
pathway for hepatocyte DNA synthesis and proliferation is shown in Fig. 
11. 
 With regard to the physiological significance of the IL-1β effects, 
Higashitsuji et al. reported that there was a transient increase in 
expression of IL-1β mRNA at 0.5 ~ 1.0 h after partial hepatectomy in vivo 
(Higashitsuji et al., 1995). Therefore, IL-1β, as a pro-inflammatory factor, 
plays an important role in liver regeneration during early phase of liver 
injury. In addition, based on the present results, IL-1β may also induce 
hepatocyte proliferation during the very early phases of liver injury in an 
autocrine manner in vivo. Studies into such processes remain to be 
conducted. 
In conclusion, we provide evidence that IL-1β, but not IL-1α, is a potent 
initiator of DNA synthesis and proliferation in primary cultures of adult rat 
hepatocytes. The IL-1β receptor/(Gq)/PLC/Ca2+-dependent autocrine 
secretion of TGF-α occurring in response to IL-1β receptor activation is an 
essential step in the stimulation of hepatocyte DNA synthesis and 
proliferation. The secreted TGF-α, in turn, acts as a primary mitogen to 
induce hepatocyte mitogenesis through the receptor tyrosine kinase/ERK 
pathway in primary cultured hepatocytes (Fig. 11). As IL-1β is the main 
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cytokine secreted by non-parenchymal hepatocytes, the regulation of 
hepatocyte proliferation is likely to involve locally produced IL-1β, 
generated in response to hepatic damage or injury, acting as an inducer 
during liver regeneration in vivo.  
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Figure Legends  
Fig. 1. Effects of IL-1α and IL-1β on hepatocyte DNA synthesis and cell 
proliferation in primary cultures of adult rat hepatocytes. Hepatocytes at a 
cell density of 3.3 × 104 cells/cm2 were plated and cultured for 3 h as 
described in Section 2.2. After an attachment period of 3 h (time zero), the 
medium was rapidly replaced with serum-free Williams’ Medium E and 
hepatocytes were cultured with IL-1α (30 ng/ml) or IL-1β (10 ng/ml) with or 
without IL-1ra (20 ng/ml) for various durations. DNA synthesis and cell 
proliferation were assessed as described in Section 2.3. Results are 
expressed as means ± S.E.M. of three separate experiments. *P<0.05, 
**P<0.01 compared with controls. 
 
Fig. 2 Effects of IL-1α and IL-1β on cell cycle progression in primary 
cultures of adult rat hepatocytes. Hepatocytes at a cell density of 3.3 × 104 
cells/cm2 were plated and cultured for 3 h as described in Section 2.2. After 
an attachment period of 3 h (time zero), the medium was rapidly replaced 
with serum-free Williams’ Medium E and hepatocytes were cultured with 
IL-1α (30 ng/ml), IL-1β (10 ng/ml), and EGF (20 ng/ml) for various 
durations. At each time point, isolated hepatocyte nuclei (105/ml) were 
subjected to cell cycle analysis (A); percent of total hepatocyte nuclei in 
G0/G1 phase, (B); percent of total hepatocyte nuclei in S phase of cell cycle. 
Arrows indicate time of cytokine addition. Results are expressed as means 
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± S.E.M. of three separate experiments. *P<0.05, **P<0.01 compared with 
control (hepatocyte nuclei before culture). #P<0.05, ##P<0.01 compared with 
respective control. 
 
Fig. 3. Dose-response effects of IL-1β on hepatocyte DNA synthesis and cell 
proliferation, and its blockade by IL-1ra in primary cultures of adult rat 
hepatocytes. Hepatocytes at a cell density of 3.3 × 104 cells/cm2 were plated 
and cultured for 3 h as described in the legend to Fig. 1. After medium 
change, cultured hepatocytes were treated with increasing concentrations 
of IL-1α (0.1-30 ng/ml) and IL-1β (0.1-30 ng/ml), without or with IL-1ra 
(0.1-30 ng/ml) for 4 h of culture. DNA synthesis and cell proliferation were 
assessed as described in Section 2.2. Results are expressed as means ± 
S.E.M. of three separate experiments. *P<0.05, **P<0.01 compared with 
control. 
 
Fig. 4. Effects of specific inhibitors of growth-related signal transducers on 
hepatocyte DNA synthesis and cell proliferation induced by IL-1β. 
Hepatocytes at a cell density of 3.3 × 104 cells/cm2 were plated and cultured 
for 3 h as described in the legend to Fig. 1. After an attachment period of 3 
h (time zero), medium was rapidly replaced with serum-free Williams’ 
Medium E, and hepatocytes were cultured with 10 ng/ml IL-1β in the 
presence or absence of specific inhibitors of growth-related signal 
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transducers for an additional 4 h. Concentrations were as follows: IL-1ra 
(20 ng/ml); U-73122 (10-6 M); U-73343 (10-6 M); GF109203X (10-6 M); 
AG1478 (10-6 M); LY294002 (3×10-7 M); PD98059 (10-6 M); and rapamycin 
(10 ng/ml). Hepatocyte DNA synthesis (A) and proliferation (B) were 
determined as described in Section 2.2. Data are expressed as means ± 
S.E.M. of three separate experiments. **P<0.01 compared with respective 
controls. 
 
Fig. 5. Effects of IL-1β on ERK phosphorylation in primary cultured 
hepatocytes. Hepatocytes at a cell density of 3.3 × 104 cells/cm2 were plated 
and cultured for 3 h as described in the legend to Fig. 1. After an 
attachment period of 3 h (time zero), medium was rapidly replaced with 
serum-free Williams’ Medium E, and hepatocytes were cultured with 10 
ng/ml IL-1β for various durations.  Phosphorylation of ERK 1/2 by IL-1β 
was assessed as described in Section 2.4. A typical Western blot image is 
shown on the top of the figure. Results are expressed as a percentage of the 
respective control value (means ± S.E.M. of three separate experiments). 
*P<0.05, **P<0.01 compared with controls. 
 
Fig.6. Effects of specific inhibitors of growth-related signal transducers on 
ERK phosphorylation induced by IL-1β. Hepatocytes at a cell density of 3.3 
× 104 cells/cm2 were plated and cultured for 3 h as described in the legend 
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to Fig. 1. After an attachment period of 3 h (time zero), medium was 
rapidly replaced with serum-free Williams’ Medium E, and hepatocytes 
were cultured with IL-1β with or without specific inhibitors of 
growth-related signal transducers for 10 min. Phosphorylation of ERK 1/2 
stimulated by IL-1β was assessed as described in Section 2.4. A typical 
Western blot image is shown on the top of the figure. Concentrations were 
as follows: (A), IL-1ra (20 ng/ml); AG1478 (10-6 M); LY294002 (3×10-7 M); 
PD98059 (10-6 M); and rapamycin (10 ng/ml); (B), U-73122 (10-6 M); 
U-73343 (10-6 M); GF109203X (10-6 M); verapamil (10-6 M); 
dideoxyadenosine (10-6 M); H-89 (10-6 M); and somatostatin (10-7 M). Results 
are expressed as a percentage of respective control values (means ± S.E.M. 
of three separate experiments). **P<0.01 compared with respective 
controls. 
 
Fig. 7. Effects of monoclonal antibodies against IGF-I and TGF-α on 
IL-1β-induced hepatocyte DNA synthesis and proliferation. Hepatocytes at 
a cell density of 3.3 × 104 cells/cm2 were plated and cultured for 3 h as 
described in the legend to Fig. 1. After an attachment period of 3 h (time 
zero), medium was rapidly replaced with serum-free Williams’ Medium E, 
and hepatocytes were cultured with various concentrations of monoclonal 
antibodies against TGF-α, and IGF-I in the presence of 10 ng/ml IL-1β for 
an additional 4 h. Hepatocyte DNA synthesis (A) and proliferation (B) were 
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determined as described in Section 2.2. and 2.5. Data are expressed as 
means ± S.E.M. of three separate experiments. *P<0.05, **P<0.01 
compared with respective controls. 
 
Fig. 8. Effects of specific inhibitors of growth-related signal transducers on 
phosphorylation of TGF-α receptor tyrosine kinase induced by IL-1β. 
Hepatocytes at a cell density of 3.3 × 104 cells/cm2 were plated and cultured 
for 3 h as described in the legend to Fig. 1. After an attachment period of 3 
h (time zero), medium was rapidly replaced with serum-free Williams’ 
Medium E, and hepatocytes were cultured with 10 ng/ml IL-1β with or 
without inhibitors of growth-related signal transducers for 3 
min. Phosphorylation of TGF-α receptor tyrosine kinase (p175 kDa) 
induced by IL-1β was assessed as described in Section 2.4. A typical 
Western blot image is shown on the top of the figure. Concentrations were 
as follows: IL-1ra (20 ng/ml); AG1478 (10-6 M); LY294002 (3×10-7 M); 
PD98059 (10-6 M); rapamycin (10 ng/ml); and U-73122 (10-6 M). Results are 
expressed as a percentage of respective control values (means ± S.E.M. of 
three separate experiments). **P<0.01 compared with respective controls. 
 
Fig. 9. IL-1β-induced secretion of TGF-α by primary cultured hepatocytes: 
time-course study (A) and dose-response relationship (B). Hepatocytes were 
isolated and cultured as described in Section 2.2. At each time point, the 
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conditioned medium (50 µL) was collected and medium samples were 
tested by ELISA for TGF-α according to the manufacturer’s instructions, as 
described in Section 2.5. Concentrations of ILs were as follows: IL-1α (30 
ng/ml); IL-1β (10 ng/ml); and IL-1ra (20 ng/ml). Results are expressed as 
means ± S.E.M. of three separate experiments. *P<0.05, **P<0.01 
compared with respective controls. 
 
Fig.10. IL-1β-induced secretion of TGF-α by primary cultured hepatocytes; 
effects of specific inhibitors of various signal transducers. Hepatocytes were 
isolated and cultured as described in Section 2.2. After 10-min incubation 
of hepatocytes with 10 ng/ml IL-1β in the presence or absence of specific 
inhibitors, conditioned medium (50 µl) was collected and medium samples 
were tested by ELISA for TGF-α in accordance with the manufacturer’s 
instructions, as described in Section 2.5. Concentrations of specific 
inhibitors of signal transducers were as follows: IL-1ra (20 ng/ml), U-73122 
(10-6 M); GF109203X (10-6 M); BAPTA/AM (10-7 M); verapamil (10-6 M); 
somatostatin (10-7 M); AG1478 (10-6 M); LY294002 (3×10-7 M); PD98059 
(10-6 M); and rapamycin (10 ng/ml). Results are expressed as means ± 
S.E.M. of three separate experiments. **P<0.01 compared with respective 
controls. 
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Fig. 11. Signal transduction pathway for IL-1β-induced DNA synthesis and 
proliferation in primary cultures of adult rat hepatocytes. Abbreviations; 
RTK: receptor tyrosine kinase; PLC: phospholipase C; PIP2: 
phosphatidylinositol 4, 5-bisphosphate; DG: diacylglycerol; IP3: inositol 1,4, 
5-trisphosphate; PI3K: phosphoinisitide 3-kinase; ERK2: extracellular 
signal-regulated kinase 2; and mTOR: mammalian target of rapamycin. 
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